Skip To Main Content
Assaf Magen on Muck Rack

Assaf Magen

As seen in: Nature, BioRxiv, Cell Press

Get in touch with Assaf

Contact Assaf, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Assaf Magen’s Biography

Read Full Bio →

See portfolio at https://assafmagen.com
Learn about my new venture Voyant Bio.

Assaf Magen’s Journalist Portfolio

Voyant Bio

Voyant Bio

Bridging scientific domains to accelerate discovery.

View article →
Assaf Magen, PhD - Entrepreneur and Consultant Profile

Assaf Magen, PhD - Entrepreneur and Consultant Profile

Assaf Magen, PhD - Entrepreneur & Consultant Profile

View article →

Articles

Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms | Nature Communications

|
By Shivan Sivakumar, Sakina Amin, David Reiss, Lara R Heij, Assaf Magen, Felicia A. Tucci, Bo Sun, Nithishwer Mouroug Anand, Hubert Slawinski, Santiago Revale, Isar Nassiri, Adam Frampton, Philip Charlton, Tim Elliott, Mark Middleton, Benjamin P. Fairfax, Miriam Merad, Michael L. Dustin, Enas Abu-Shah
| Nature Verified
Abstract Pancreatic ductal adenocarcinoma has a dismal prognosis. A comprehensive analysis of single-cell multi-omic data from matched tumour-infiltrated CD45+ cells and peripheral blood in 12 patients, and two published datasets, reveals a complex immune infiltrate. Patients have either a myeloid-enriched or adaptive-enriched tumour microenvironment. Adaptive immune cell-enriched is intrinsically linked with highly distinct B and T cell clonal selection, diversification, and differentiation.
Open in Who Shared Issue with article?

A network diffusion approach to inferring sample-specific function reveals functional changes associated with breast cancer

|
By Assaf Magen
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (594) Issue with article?

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma - Nature Medicine

|
By Assaf Magen, Raphaël Mattiuz, Leanna Troncoso, Travis Dawson, Edgar Gonzalez-Kozlova, Kamil J. Cygan, Namita T. Gupta, Sacha Gnjatic, Ephraim Kenigsberg, Myron Schwartz, Thomas U Marron, Gavin Thurston
| Nature Verified
Abstract Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T cell rich tumors fail to respond to immune checkpoint blockade (ICB). We leveraged a neoadjuvant anti-PD-1 trial in patients with hepatocellular carcinoma (HCC), as well as additional samples collected from patients treated off-label, to explore correlates of response to ICB within T cell-rich tumors.
Open in Who Shared Issue with article?
See all 17 articles